Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - TOTAL LIABILITIES
Total Liabilities VKTX - Viking Therapeutics, Inc.
20.1 M
LAST VALUE
51.21%
2 YEAR CAGR
34.49%
5 YEAR CAGR
46.83%
10 YEAR CAGR